Genetics of rheumatoid arthritis contributes to biology and drug discoveryYukinori Okada, René E. M. Toes, Robert Graham et al.|Nature|2013Cited by 2.5k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A. Singh, Kenneth G. Saag, Daniel E. Fürst et al.|Arthritis Care & Research|2012Cited by 1.8k
Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis PatientsTheodore Mellors, Viatcheslav R. Akmaev, Johanna B. Withers et al.|Network and Systems Medicine|2020Cited by 42
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyStanley Cohen, Viatcheslav R. Akmaev, Jeffrey R. Curtis et al.|Rheumatology and Therapy|2021Cited by 34
AB0286 A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-To-Target Approach in the Clinical Care of Rheumatoid Arthritis PatientsLeslie R. Harrold, Joel M. Kremer, George Reed et al.|Annals of the Rheumatic Diseases|2015Cited by 5